Direct-to-Consumer Advertising of Drugs Using Television Draft: Beneficial or Detrimental to Public Health?
Direct to Consumer Advertising of Drugs Using Television Draft
Marion Simmons
Rasmussen College
Author Note
Direct-to-Consumer Advertising of Drugs Using Television Draft
Introduction
The last three decades haves seen rapid growth in direct-to-consumer (DTC) advertising. As such, advertising of pharmaceutical drugs has become an integral strategy in pharmaceutical services and products. However, numerous health experts have raised questions as to whether DTC advertising is beneficial or detrimental to the health of the public. Accordingly, the paper will evaluate how advertising prescription drugs over Television impacts on the health of the viewers.
Thesis Statement
Although DTC advertising has its drawbacks, the benefits outweigh them. As such, with the proper regulation, DTC will help improve public health.
Growth of DTC Advertising
Early Regulation
At the beginning of the 1980s, the majority of the governments were resentful of DTC advertising. Therefore, prescription drugs could only be advertised in medical journals and health care publications dedicated to physicians (Frosch; Grande, 2009). However, in 1983 Food and Drugs Administration commissioner, Arthur Hull Hayes requested for independent evaluation of DTC advertising following concerns from pharmaceutical industry players. In 1985, FDA gave the green light to FDA advertising (Frosch; Grande, 2009).
Driving Force
Several factors have the force behind the growth of DTC advertising. First, structural changes in the health care market (Galled; Lyles, 2007). Secondly, increased interest by consumers to know more about prescription drugs have also facilitated in the notable growth in DTC advertising (Galled; Lyles, 2007). Lastly, a favorable political and regulatory climate geared towards giving consumers access to health information has been a catalyst for the growth of DTC in televisions.
Public Policy Issues
Several public policy issues have risen after the growth of DTC
Marion Simmons
Rasmussen College
Author Note
Direct-to-Consumer Advertising of Drugs Using Television Draft
Introduction
The last three decades haves seen rapid growth in direct-to-consumer (DTC) advertising. As such, advertising of pharmaceutical drugs has become an integral strategy in pharmaceutical services and products. However, numerous health experts have raised questions as to whether DTC advertising is beneficial or detrimental to the health of the public. Accordingly, the paper will evaluate how advertising prescription drugs over Television impacts on the health of the viewers.
Thesis Statement
Although DTC advertising has its drawbacks, the benefits outweigh them. As such, with the proper regulation, DTC will help improve public health.
Growth of DTC Advertising
Early Regulation
At the beginning of the 1980s, the majority of the governments were resentful of DTC advertising. Therefore, prescription drugs could only be advertised in medical journals and health care publications dedicated to physicians (Frosch; Grande, 2009). However, in 1983 Food and Drugs Administration commissioner, Arthur Hull Hayes requested for independent evaluation of DTC advertising following concerns from pharmaceutical industry players. In 1985, FDA gave the green light to FDA advertising (Frosch; Grande, 2009).
Driving Force
Several factors have the force behind the growth of DTC advertising. First, structural changes in the health care market (Galled; Lyles, 2007). Secondly, increased interest by consumers to know more about prescription drugs have also facilitated in the notable growth in DTC advertising (Galled; Lyles, 2007). Lastly, a favorable political and regulatory climate geared towards giving consumers access to health information has been a catalyst for the growth of DTC in televisions.
Public Policy Issues
Several public policy issues have risen after the growth of DTC